
The Company: Healthcare Communications Group ("HCG") has established a leadership position as a niche consulting and advertising firm accelerating patient recruitment for pharmaceutical clinical research studies. Healthcare's services provide afflicted patients the opportunity to gain access to new, sometimes revolutionary, treatments that are not yet FDA-approved.
With on-time subject accrual failing for more than 80% of clinical trials, improving these timetables substantially impacts drug development timelines and society. HCG's trial recruitment services have been shown to reduce drug development schedules by up to 50%, making a tangible impact on people's lives by allowing pharmaceutical companies to bring these new therapies to market in a shorter time frame.
Whether in planned or "rescue" situations, Healthcare has earned its reputation for providing recognized solutions and delivering outstanding service while adhering to the highest clinical and ethical standards. We offer the pharmaceutical industry's most comprehensive and focused array of customized recruitment tools-including our unique clinically-based programs-to reach difficult-to-find subject populations for Phase II, III, and IV trials within virtually every therapeutic area.
Learn more about the company at www.hcg.com.
On Why They Have Entered The American Business Awards: "Last year I was privileged to be among the nominees," said Jeanne Floyd, Vice President and Chief Operating Officer. "The breadth of achievement honored was as impressive as it was inspirational. This year, HCG chose to nominate our project support team for hard fought and won business success that ultimately may impact the health of millions of women. It's a story we are proud to share."
|